INCYCLIX

Welcome to the Brand page for “INCYCLIX”, which is offered here for Pharmaceutical research and development services in the field of oncology; research and development of pharmaceuticals and therapeutics in the field oncology; pharmaceutical product development services in the field of cyclin-dependent kinases (cdks) for the treatment of advanced and resistant cancers; scientific research for medical purposes in the area of cancerous diseases; research and development of cyclin-dependent kinase (cdk) based pharmaceuticals for the treatment of cancer and oncological conditions; research and development in the field of cyclin-dependent kinases (cdks) for the treatment of advanced and resistant cancers; providing information about medical research in the field of cancerous diseases;.

Its status is currently believed to be active. Its class is unavailable. “INCYCLIX” is believed to be currently owned by “Incyclix Bio, LLC”.


Owner:
INCYCLIX BIO, LLC
Owner Details
Description:
Pharmaceutical research and development services in the field of oncology; Research and development of pharmaceuticals and therapeutics in the field oncology; Pharmaceutical product development services in the field of cyclin-dependent kinases (CDKs) for the treatment of advanced and resistant cancers; Scientific research for medical purposes in the area of cancerous diseases; Research and development of cyclin-dependent kinase (CDK) based pharmaceuticals for the treatment of cancer and oncological conditions; Research and development in the field of cyclin-dependent kinases (CDKs) for the treatment of advanced and resistant cancers; Providing information about medical research in the field of cancerous diseases;
Categories: PHARMACEUTICAL RESEARCH DEVELOPMENT SERVICES